Geeky News Explores the Role of Digital Solutions in Oncology Studies

Oct 24, 2023



Surrey, United Kingdom Oct 24, 2023 (Issuewire.com) - Geeky News, a leading technology and lifestyle journal, presents an in-depth discussion of a groundbreaking study titled "Unlocking digitally enabled research in oncology: the time is now." The study was published in ESMO Open, a renowned platform for oncology research. It addresses the critical need for innovation in clinical oncology trials and paves the way for a more inclusive and efficient approach.

Geeky News goes through the findings of the study in its article, titled "Digitally Enabled Oncology Research: A Breakthrough for Patient Inclusion,".

Over the past five decades, advancements in oncology therapeutics, screening, and supportive care have significantly improved the survival rates of cancer patients. Central to this progress are clinical trials, which have been instrumental in translating research findings into tangible patient benefits. However, these trials are not without their challenges, primarily due to their high cost and exclusionary nature.

The study reveals that traditional oncology trials are expensive, with the median cost of pivotal trials being approximately $31.7 million. Per-patient costs for phase III trials have seen a significant increase since 1996. Additionally, the arduous and lengthy process of traditional trials limits their geographical reach, concentrating them in a limited number of cancer centers.

One of the most glaring issues highlighted by the study is the lack of inclusivity in traditional clinical trials. That results in low recruitment rates, particularly for ethnic minorities, socioeconomic groups, the elderly, and individuals in remote areas. Racial and ethnic minorities, despite being disproportionately affected by certain diseases, are significantly underrepresented in clinical studies.

The study emphasises the urgent need to leverage digital technologies in clinical cancer research to address these challenges. Oncology clinical trials that embrace digital technologies see a significant improvement in accuracy, patient recruitment, and retention rates. Digital technology simplifies trial procedures, expedites data collection, promotes global outreach, and fosters patient empowerment.

Democratising patient screening, enrollment, consent, and follow-ups can significantly reduce patient burden and drop-out rates. Artificial intelligence (AI)-enabled tools, such as machine learning and natural language processing, streamline patient eligibility assessments and reduce screening time. Furthermore, digital clinical trial (DCT) platforms--like ObvioHealth--including eConsent and electronic patient-reported outcomes (ePROs), enhance data accuracy, reduce errors, and improve patient compliance.

The study highlights the impact of biosensors and ePROs in collecting clinical data and patient-generated health data (PGHD). The use of these tools provides in-depth insights into a patient's health, treatment impacts, quality of life, and toxicities. Compliance rates in ePRO-based clinical trials are significantly higher compared to paper-based trials.

The deployment of decentralised and hybrid models in clinical trials helps bridge geographical and demographic gaps by enabling underrepresented populations to participate remotely. The potential for digitally enabled clinical trials in oncology is immense, but it also comes with certain challenges.

The study underscores the importance of secure data storage and transmission in oncology clinical trials. Robust identity protocols and encryption processes are essential for safeguarding patient data. Additionally, the development of patient-oriented regulatory frameworks is crucial for the success of DCT models.

While the initial cost of implementing fully decentralised and digitally enabled clinical research may seem high, the long-term benefits, including improved data quality and reduced costs, make it a worthwhile investment. Digitally enabled research accelerates the development and rollout of life-saving and life-improving therapeutics to the market.

The publication of this study marks a significant milestone in the advancement of oncology research. ESMO Open and Geeky News are committed to driving change and inclusivity in clinical trials, ultimately benefiting patients worldwide.

To read the full article, please visit: https://www.geekynews.co.uk/digitally-enabled-oncology-research/

Media Contact

Geeky News


[email protected]

+44 20 3800 1212

Parallel House, 32 London Road Guildford, Surrey

https://www.geekynews.co.uk/

Source :Geeky News

This article was originally published by IssueWire. Read the original article here.

More News

Novo Nordisk Warns of First Sales Drop Since Start of Ozempic
Feb 4, 2026
Novo Nordisk Warns of First Sales Drop Since Start of Ozempic

The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, which gave a much rosier outlook to investors.

Why A.I. Fears Are Battering Stocks, Again
Feb 4, 2026
Why A.I. Fears Are Battering Stocks, Again

New tools by artificial intelligence companies like Anthropic have reignited worries that businesses will pare down their subscriptions to software services.

The Questionable Science Behind the Odd-Looking Football Helmets
Feb 4, 2026
The Questionable Science Behind the Odd-Looking Football Helmets

The N.F.L. claims Guardian Caps reduce the risk of concussions. The company that makes them says, “It has nothing to do with concussions.”

Restaurant boss 'devastated' at having to close
Feb 4, 2026
Restaurant boss 'devastated' at having to close

Bar owner Jobe Ferguson says he is devastated to close TNQ in the Northern Quarter after 22 years.

New York Times Added 1.4 Million Digital Subscribers in 2025
Feb 4, 2026
New York Times Added 1.4 Million Digital Subscribers in 2025

The company reported total revenue of $802.3 million for the fourth quarter of 2025, up 10.4 percent from a year earlier.

Are You ‘Biohacking’ to Perform Better at Work? We Want to Hear From You.
Feb 4, 2026
Are You ‘Biohacking’ to Perform Better at Work? We Want to Hear From You.

Please tell us what changes you’ve made to your health and wellness practices to improve your brain function and job performance. We may include your experiences in an article.

Wegovy maker warns price cuts 'painful' for firm as shares plunge
Feb 4, 2026
Wegovy maker warns price cuts 'painful' for firm as shares plunge

Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.

Bedrock, an A.I. Start-Up for Construction, Raises $270 Million
Feb 4, 2026
Bedrock, an A.I. Start-Up for Construction, Raises $270 Million

The two-year-old company, founded by veterans of the autonomous vehicle business Waymo, is seeking to automate excavators and other building equipment.

Gold rebounds above $5,000 after US downs Iran drone
Feb 4, 2026
Gold rebounds above $5,000 after US downs Iran drone

Precious metal price voliatility continues as geopolitical tensions push investors to safe-haven assets.

The yachting industry searches for alternatives to teak
Feb 4, 2026
The yachting industry searches for alternatives to teak

Prized for its beauty, teak is in short supply, forcing the yacht industry to look for alternatives.

How will car loan compensation payments work?
Feb 4, 2026
How will car loan compensation payments work?

Millions could be entitled to compensation as a result of commission arrangements between lenders and dealers.

Bulgarians Adopt the Euro With a Whisper of Melancholy but Few Tears
Feb 4, 2026
Bulgarians Adopt the Euro With a Whisper of Melancholy but Few Tears

In a country roiled by political upheaval recently, retiring the longtime currency, the lev, prompted some concern about inflation but little other angst.

Trump Says Housing Prices Should Be Higher, Not Lower
Feb 4, 2026
Trump Says Housing Prices Should Be Higher, Not Lower

When President Trump said he wanted to drive housing prices up, not down, he was speaking to a conundrum that has flummoxed policymakers for decades.

Congress Reins In Drug Middlemen in Effort to Lower Prescription Prices
Feb 4, 2026
Congress Reins In Drug Middlemen in Effort to Lower Prescription Prices

The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and Express Scripts that oversee prescription drug benefits.

What's going on with the price of gold?
Feb 4, 2026
What's going on with the price of gold?

Gold has fallen from recent highs but there are several reasons investors are still finding refuge in the precious metal.

Pinterest sacks engineers for tracking staff job cuts
Feb 4, 2026
Pinterest sacks engineers for tracking staff job cuts

The social media platform recently announced that it was axing around 15% of its workforce.

‘Neoroyalism’ and What It Says About Trump
Feb 4, 2026
‘Neoroyalism’ and What It Says About Trump

Experts are reaching to divine the president’s approach to global policy and economics, with one theory seeing antecedents in centuries-old dynastic rule.

Meat Processors Take a Hit as Cattle Prices Remain High
Feb 4, 2026
Meat Processors Take a Hit as Cattle Prices Remain High

Tyson Foods said its beef business could lose up to $500 million this year as the supply of cattle reaches a 75-year low.

Grammy Awards Audience Declines by a Million Viewers
Feb 4, 2026
Grammy Awards Audience Declines by a Million Viewers

The show on Sunday drew about 14.4 million people. It is the second consecutive year that the awards ceremony attracted a smaller audience.

X offices raided in France as UK opens fresh investigation into Grok
Feb 4, 2026
X offices raided in France as UK opens fresh investigation into Grok

Elon Musk's X and Grok platforms are facing increased scrutiny from authorities on both sides of the channel.

Stephen Miran Resigns From White House as Fed Term Stretches On
Feb 3, 2026
Stephen Miran Resigns From White House as Fed Term Stretches On

Mr. Miran had taken a leave of absence from advising the president after adding a role at the Federal Reserve, drawing criticism from Democrats.

Netflix Leader Pushes Warner Deal Before Skeptical Lawmakers
Feb 3, 2026
Netflix Leader Pushes Warner Deal Before Skeptical Lawmakers

Senators asked Ted Sarandos about whether the acquisition would raise prices, squeeze talent and degrade the moviegoing experience.

Netflix and Warner Bros struggle to defend merger
Feb 3, 2026
Netflix and Warner Bros struggle to defend merger

Concerns were raised by a subcommittee including potential price rises and the future of cinemas.

The Chinese planemaker taking on Boeing and Airbus
Feb 3, 2026
The Chinese planemaker taking on Boeing and Airbus

Comac's passenger jet is attracting customers in South East Asia where demand for affordable aircraft is growing.

Walmart Joins Tech Giants With $1 Trillion Market Valuation
Feb 3, 2026
Walmart Joins Tech Giants With $1 Trillion Market Valuation

The company’s rapid e-commerce growth and push into automation and artificial intelligence propelled its stock into the trillion-dollar club.

Snow Drought, Political Shifts and Strikes Batter Ski Industry in Western U.S.
Feb 3, 2026
Snow Drought, Political Shifts and Strikes Batter Ski Industry in Western U.S.

Little snowpack, strikes by mountain staff and Trump administration policies that are keeping international visitors away have made this a difficult season in the Rockies and beyond.

Police Search X’s Premises in France as Prosecutors Summon Elon Musk
Feb 3, 2026
Police Search X’s Premises in France as Prosecutors Summon Elon Musk

The move followed a yearlong investigation into X and escalated a wider standoff between European officials and American tech companies over the regulation of social media.

‘Don Colossus,’ a Golden Statue of President Trump, Waits for Its Home
Feb 3, 2026
‘Don Colossus,’ a Golden Statue of President Trump, Waits for Its Home

A group of cryptocurrency investors backing a memecoin hopes the statue will soon be installed at one of Mr. Trump’s golf courses in Florida.

Trump and India Call Off Their Trade War, but the Terms of Peace Are Murky
Feb 3, 2026
Trump and India Call Off Their Trade War, but the Terms of Peace Are Murky

Officials and business leaders welcomed lower tariffs, but India has not yet confirmed that it would stop buying Russian oil, which President Trump said Prime Minister Narendra Modi had agreed to.

Brad Karp Says He Regrets Interactions with Epstein
Feb 3, 2026
Brad Karp Says He Regrets Interactions with Epstein

Newly released emails between Mr. Karp, the chairman of Paul Weiss, and Jeffrey Epstein reveal a number of social interactions between them.

Disney names Josh D'Amaro as new chief executive
Feb 3, 2026
Disney names Josh D'Amaro as new chief executive

The media giant chooses the head of its amusement park business to replace longtime boss Bob Iger.

Jeffrey Epstein’s Trust Reveals Beneficiaries of His Fortune
Feb 3, 2026
Jeffrey Epstein’s Trust Reveals Beneficiaries of His Fortune

Jeffrey Epstein wanted most of his money to go to his girlfriend. Mr. Epstein’s brother and a Harvard math professor were also named beneficiaries.

After Years of Increases, PepsiCo Pledges to Cut Prices on Snacks
Feb 3, 2026
After Years of Increases, PepsiCo Pledges to Cut Prices on Snacks

The food and beverage giant said consumers were facing “affordability limitations.”

Investigation Finds Credit Suisse Had Wider Nazi Ties Than Previously Known
Feb 3, 2026
Investigation Finds Credit Suisse Had Wider Nazi Ties Than Previously Known

But a lawyer who has been scrutinizing archives and UBS are in a dispute over access to about 150 documents.

Walmart becomes first retailer to hit $1tn market value
Feb 3, 2026
Walmart becomes first retailer to hit $1tn market value

The milestone reflects the US retail giant's booming e-commerce business and investors' embrace of its AI investments.

The New Key to Restaurant Success? A Simple but Clever Model.
Feb 3, 2026
The New Key to Restaurant Success? A Simple but Clever Model.

Novel approaches to the all-day cafe are working for diners and creative chefs across the country.

PepsiCo to cut some US snack prices after backlash
Feb 3, 2026
PepsiCo to cut some US snack prices after backlash

The snack conglomerate is cutting the price of products including Doritos, Cheetos and Lays

Disney Names Josh D’Amaro as Next C.E.O.
Feb 3, 2026
Disney Names Josh D’Amaro as Next C.E.O.

Mr. D’Amaro, 54, has most recently served as chairman of Disney Experiences, a division that includes theme parks, cruise vacations and consumer products.

Christy Tanner Named C.E.O. of New York Public Radio
Feb 3, 2026
Christy Tanner Named C.E.O. of New York Public Radio

Ms. Tanner was previously an executive at CBS News and serves on the board of Audacy, a major U.S. broadcaster and podcast producer.

Stop watching Netflix and go to the pub, Welsh first minister says
Feb 3, 2026
Stop watching Netflix and go to the pub, Welsh first minister says

Eluned Morgan said her government can't be expected "to step in and do the work" to save struggling pubs.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Manage The Numbers

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Newsletter